Key result
Updated 2024 HF classification reveals notable physician staging discrepancies compared to 2020 criteria.
Why the study?
Following the October 2024 release of revised Russian Ministry of Health HF guidelines, it was unknown how accurately physicians apply the new HF staging classification in clinical practice compared with the previous 2020 classification.
Does the 2024 Russian Society of Cardiology HF staging classification accurately align with the 2020 classification when applied by practicing physicians in patients with heart failure?
Observational (n=13,902)
Yes
Does the 2024 Russian Society of Cardiology HF staging classification accurately align with the 2020 classification when applied by practicing physicians in patients with heart failure?
Real-world analysis of the Russian HOSTA-CHF registry reveals substantial discrepancies and inaccuracies in how practicing physicians apply the new 2024 heart failure staging guidelines compared to the 2020 criteria, highlighting a need for better clinician education and more objective staging criteria.
Answers are grounded in this paper and cite their sources.
Variable physician use of revised HF staging warrants diagnostic caution; leaves open need for education and validation studies.
Aim . To evaluate and compare the application and interpretation of heart failure stages by physicians based on the criteria of the previous and new classifications of heart failure (HF). Material and methods . In October 2024, the new guidelines of the Russian Ministry of Health on HF, with revised classifications of HF stages, came into effect. It is unknown how accurately physicians apply the changes in the HF staging classification in practice. Data on diagnoses of 13902 patients with HF from the interregional registry HOSTA-CHF were analyzed. HF stages in the registry were reported using both classifications, in accordance with the 2020 and 2024 clinical guidelines of the Russian Society of Cardiology. Results. The distribution of HF stages in the HOSTA-CHF registry is presented as follows: according to the 2024 HF classification, prestage HF accounts for 8%, stage 1 — 71%, and stage 2 — 21%; and according to the 2020 HF classification, stage I accounts for 16%, stage II A – 65%, stage II B — 17%, and stage III — 2%. Seventy percent of patients with pre-stage HF were reported as having stage I, 29% as having stage IIA, and 1% as having stage IIB, according to the 2020 classification. Seventy-four percent of patients with stage 1 HF according to the new classification were classified as stage IIA, 10% as stage IIB, and 16% as stage I according to the 2020 classification. Stage 2 according to the new classification was classified as stage 1 HF in 1% of patients, stage IIA in 52%, stage IIB in 39%, and stage III in 8% of patients according to the 2020 classification. Conclusion . Analysis of the interim results of the HOSTA-HF interregional registry showed that practicing physicians are not accurately determining the HF stages according to the new 2024 HF classification, particularly pre-stage HF. Furthermore, discrepancies were identified in the definition of HF stages 1 and 2, likely due to the subjective nature of the criteria used, which reflect solely HF symptoms and response to therapy, but do not take into account the persistent, objective morphological and structural changes. Further work is required with all participants in the care of HF patients to avoid the repetition of incorrect diagnosis formulations and possible treatment errors, as well as the inevitable difficulties associated with medical and social assessment, statistical accounting, and healthcare budget planning.
No takes yet. Share an insight, caveat, or question.
Ageev et al. (2026) conducted an observational in Heart Failure (n=13,902). 2024 Russian Society of Cardiology heart failure staging classification vs. 2020 Russian Society of Cardiology heart failure staging classification was evaluated on Distribution and concordance of heart failure stages between 2024 and 2020 classifications. The 2024 HF classification identified 8% prestage, 71% stage 1, and 21% stage 2 HF, showing notable physician staging discrepancies compared to the 2020 criteria.
Synapse has enriched 10 related papers. Consider them for comparative context: